AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
PREVENTION OF CORONARY HEART-DISEASE IN CLINICAL-PRACTICE - SUMMARY OF RECOMMENDATIONS OF THE 2ND JOINT TASK-FORCE OF EUROPEAN AND OTHER SOCIETIES ON CORONARY PREVENTION
Authors: WOOD D DEBACKER G FAERGEMAN O GRAHAM L MANCIA G PYORALA K
Citation: D. Wood et al., PREVENTION OF CORONARY HEART-DISEASE IN CLINICAL-PRACTICE - SUMMARY OF RECOMMENDATIONS OF THE 2ND JOINT TASK-FORCE OF EUROPEAN AND OTHER SOCIETIES ON CORONARY PREVENTION, Journal of hypertension, 16(10), 1998, pp. 1407-1414
PREVENTION OF CORONARY-HEART-DISEASE IN CLINICAL-PRACTICE
Authors: WOOD D DEBACKER G FAERGEMAN O GRAHAM I MANCIA G PYORALA K
Citation: D. Wood et al., PREVENTION OF CORONARY-HEART-DISEASE IN CLINICAL-PRACTICE, European heart journal, 19(10), 1998, pp. 1434-1503
DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: FAERGEMAN O KJEKSHUS J COOK T PYORALA K WILHELMSEN L THORGEIRSSON G PEDERSEN TR
Citation: O. Faergeman et al., DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), European heart journal, 19(10), 1998, pp. 1531-1537
HYPERTRIGLYCERIDEMIA AND CORONARY HEART-DISEASE
Authors: FAERGEMAN O
Citation: O. Faergeman, HYPERTRIGLYCERIDEMIA AND CORONARY HEART-DISEASE, Atherosclerosis (Amsterdam), 138, 1998, pp. 4-4
FLOW-CYTOMETRY WITH A MONOCLONAL-ANTIBODY TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR COMPARED WITH GENE MUTATION DETECTION IN DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: RAUNGAARD B HEATH F BRORHOLTPETERSEN JU JENSEN HK FAERGEMAN O
Citation: B. Raungaard et al., FLOW-CYTOMETRY WITH A MONOCLONAL-ANTIBODY TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR COMPARED WITH GENE MUTATION DETECTION IN DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Clinical chemistry, 44(5), 1998, pp. 966-972
EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY
Authors: PEDERSEN TR WILHELMSEN L FAERGEMAN O STRANDBERG T THORGEIRSSON G TROEDSSON L KRISTIANSON J COOK TJ KJEKSHUS J
Citation: Tr. Pedersen et al., EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY, Circulation, 98(17), 1998, pp. 2370-2370
LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
Authors: PEDERSEN TR OLSSON AG FAERGEMAN O KJEKSHUS J WEDEL H BERG K WILHELMSEN L HAGHFELT T THORGEIRSSON G PYORALA K MIETTINEN T CHRISTOPHERSEN B TOBERT JA MUSLINER TA COOK TJ
Citation: Tr. Pedersen et al., LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY, Circulation, 97(15), 1998, pp. 1453-1460
PHENOTYPIC VARIATION IN PATIENTS HETEROZYGOUS FOR FAMILIAL DEFECTIVE APOLIPOPROTEIN-B (FDB) IN 3 EUROPEAN COUNTRIES
Authors: HANSEN PS DEFESCHE JC KASTELEIN JJP GERDES LU FRAZA L GERDES C TATO F JENSEN HK JENSEN LG KLAUSEN IC FAERGEMAN O SCHUSTER H
Citation: Ps. Hansen et al., PHENOTYPIC VARIATION IN PATIENTS HETEROZYGOUS FOR FAMILIAL DEFECTIVE APOLIPOPROTEIN-B (FDB) IN 3 EUROPEAN COUNTRIES, Arteriosclerosis, thrombosis, and vascular biology, 17(4), 1997, pp. 741-747
2 MUTATIONS IN THE SAME LOW-DENSITY-LIPOPROTEIN RECEPTOR ALLELE ACT IN SYNERGY TO REDUCE RECEPTOR FUNCTION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: JENSEN HK JENSEN TG FAERGEMAN O JENSEN LG ANDRESEN BS CORYDON MJ ANDREASEN PH HANSEN PS HEATH F BOLUND L GREGERSEN N
Citation: Hk. Jensen et al., 2 MUTATIONS IN THE SAME LOW-DENSITY-LIPOPROTEIN RECEPTOR ALLELE ACT IN SYNERGY TO REDUCE RECEPTOR FUNCTION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Human mutation, 9(5), 1997, pp. 437-444
APOLIPOPROTEIN(A) GENOTYPES IN A SCANDINAVIAN POPULATION - ALLELE FREQUENCIES, CORRELATION TO APOLIPOPROTEIN(A) PHENOTYPES AND LIPOPROTEIN(A) CONCENTRATIONS
Authors: LEMMING L KLAUSEN IC GERDES LU HANSEN PS FAERGEMAN O
Citation: L. Lemming et al., APOLIPOPROTEIN(A) GENOTYPES IN A SCANDINAVIAN POPULATION - ALLELE FREQUENCIES, CORRELATION TO APOLIPOPROTEIN(A) PHENOTYPES AND LIPOPROTEIN(A) CONCENTRATIONS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(1), 1997, pp. 1-7
CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997)
Authors: PYORALA K PEDERSEN TR KJEKSHUS J FAERGEMAN O OLSSON AG THORGEIRSSON G
Citation: K. Pyorala et al., CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997), Diabetes care, 20(6), 1997, pp. 1048-1048
CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: PYORALA K PEDERSEN TR KJEKSHUS J FAERGEMAN O OLSSON AG THORGEIRSSON G
Citation: K. Pyorala et al., CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Diabetes care, 20(4), 1997, pp. 614-620
TRIGLYCERIDES ARE AN INDEPENDENT RISK FACTOR FOR CORONARY HEART-DISEASE - A DEBATE
Authors: AUSTIN M THOMPSON GR HULLEY SB FAERGEMAN O WOOD D
Citation: M. Austin et al., TRIGLYCERIDES ARE AN INDEPENDENT RISK FACTOR FOR CORONARY HEART-DISEASE - A DEBATE, Atherosclerosis, 134(1-2), 1997, pp. 16-16
LIPOPROTEIN-LIPASE VARIANTS ASP9-]ASN AND ASP291-]SER ARE ASSOCIATED WITH INCREASED PLASMA TRIGLYCERIDE AND LOWER HDL CHOLESTEROL CONCENTRATIONS - STUDIES IN THE FASTING AND POSTPRANDIAL STATES
Authors: GERDES C FISHER RM NICAUD V BOER J HUMPHRIES SE TALMUD PJ FAERGEMAN O
Citation: C. Gerdes et al., LIPOPROTEIN-LIPASE VARIANTS ASP9-]ASN AND ASP291-]SER ARE ASSOCIATED WITH INCREASED PLASMA TRIGLYCERIDE AND LOWER HDL CHOLESTEROL CONCENTRATIONS - STUDIES IN THE FASTING AND POSTPRANDIAL STATES, Atherosclerosis, 134(1-2), 1997, pp. 68-68
FUNCTIONAL-CHARACTERIZATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-MUTATIONS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: RAUNGAARD B HEATH F BRORHOLTPETERSEN JU JENSEN HK FAERGEMAN O
Citation: B. Raungaard et al., FUNCTIONAL-CHARACTERIZATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-MUTATIONS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 134(1-2), 1997, pp. 361-361
APOLIPOPROTEIN(A) ISOFORMS AND CORONARY HEART-DISEASE IN MEN - A NESTED CASE-CONTROL STUDY
Authors: KLAUSEN IC SJOL A HANSEN PS GERDES LU MOLLER L LEMMING L SCHROLL M FAERGEMAN O
Citation: Ic. Klausen et al., APOLIPOPROTEIN(A) ISOFORMS AND CORONARY HEART-DISEASE IN MEN - A NESTED CASE-CONTROL STUDY, Atherosclerosis, 132(1), 1997, pp. 77-84
A COMMON W556S MUTATION IN THE LDL RECEPTOR GENE OF DANISH PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA ENCODES A TRANSPORT-DEFECTIVE PROTEIN
Authors: JENSEN HK HOLST H JENSEN LG JORGENSEN MM ANDREASEN PH JENSEN TG ANDRESEN BS HEATH F HANSEN PS NEVE S KRISTIANSEN K FAERGEMAN O KOLVRAA S BOLUND L GREGERSEN N
Citation: Hk. Jensen et al., A COMMON W556S MUTATION IN THE LDL RECEPTOR GENE OF DANISH PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA ENCODES A TRANSPORT-DEFECTIVE PROTEIN, Atherosclerosis, 131(1), 1997, pp. 67-72
LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: PEDERSEN TR KJEKSHUS J BERG K FAERGEMAN O MIETTINEN T OLSSON AG
Citation: Tr. Pedersen et al., LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Atherosclerosis, 130, 1997, pp. 21-21
IDENTIFYING THE HIGH-RISK PATIENT FOR LIPID-LOWERING THERAPY
Authors: FAERGEMAN O
Citation: O. Faergeman, IDENTIFYING THE HIGH-RISK PATIENT FOR LIPID-LOWERING THERAPY, Atherosclerosis, 130, 1997, pp. 89-89
CHANGES IN ATTITUDE TO DETECTION AND TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AFTER DNA-DIAGNOSIS
Authors: ANDERSEN LK JENSEN HK FAERGEMAN O
Citation: Lk. Andersen et al., CHANGES IN ATTITUDE TO DETECTION AND TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AFTER DNA-DIAGNOSIS, Atherosclerosis, 129(1), 1997, pp. 16-16
LIPOPROTEIN-LIPASE VARIANTS D9N AND N291S, ARE ASSOCIATED WITH INCREASED PLASMA TRIGLYCERIDE AND LOWER HIGH-DENSITY-LIPOPROTEIN CHOLESTEROLCONCENTRATIONS - STUDIES IN THE FASTING AND POSTPRANDIAL STATES - THEEUROPEAN ATHEROSCLEROSIS RESEARCH STUDIES
Authors: GERDES C FISHER RM NICAUD V BOER J HUMPHRIES SE TALMUD PJ FAERGEMAN O
Citation: C. Gerdes et al., LIPOPROTEIN-LIPASE VARIANTS D9N AND N291S, ARE ASSOCIATED WITH INCREASED PLASMA TRIGLYCERIDE AND LOWER HIGH-DENSITY-LIPOPROTEIN CHOLESTEROLCONCENTRATIONS - STUDIES IN THE FASTING AND POSTPRANDIAL STATES - THEEUROPEAN ATHEROSCLEROSIS RESEARCH STUDIES, Circulation, 96(3), 1997, pp. 733-740
CHOLESTEROL-LOWERING THERAPY IN WOMEN AND ELDERLY PATIENTS WITH MYOCARDIAL-INFARCTION OR ANGINA-PECTORIS - FINDINGS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: MIETTINEN TA PYORALA K OLSSON AG MUSLINER TA COOK TJ FAERGEMAN O BERG K PEDERSEN T KJEKSHUS J
Citation: Ta. Miettinen et al., CHOLESTEROL-LOWERING THERAPY IN WOMEN AND ELDERLY PATIENTS WITH MYOCARDIAL-INFARCTION OR ANGINA-PECTORIS - FINDINGS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Circulation, 96(12), 1997, pp. 4211-4218
PATIENTS ATTITUDES TOWARD DETECTION OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: ANDERSEN LK JENSEN HK JUUL S FAERGEMAN O
Citation: Lk. Andersen et al., PATIENTS ATTITUDES TOWARD DETECTION OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Archives of internal medicine, 157(5), 1997, pp. 553-560
ALLELE-SPECIFIC MEASUREMENT OF LOW-DENSITY-LIPOPROTEIN RECEPTOR TRANSCRIPT LEVELS
Authors: JENSEN LG JENSEN HK HEATH F EIBERG H KJELDSEN M FAERGEMAN O KOLVRAA S BOLUND L GREGERSEN N
Citation: Lg. Jensen et al., ALLELE-SPECIFIC MEASUREMENT OF LOW-DENSITY-LIPOPROTEIN RECEPTOR TRANSCRIPT LEVELS, Human mutation, 8(2), 1996, pp. 126-133
2 POINT MUTATIONS (313-]A AND 313+1G-]T) IN THE SPLICE DONOR SITE OF INTRON-3 OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE ARE ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIA(1G)
Authors: JENSEN HK JENSEN LG HANSEN PS FAERGEMAN O GREGERSEN N
Citation: Hk. Jensen et al., 2 POINT MUTATIONS (313-]A AND 313+1G-]T) IN THE SPLICE DONOR SITE OF INTRON-3 OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE ARE ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIA(1G), Human mutation, 7(3), 1996, pp. 269-271
Risultati: 1-25 | 26-50 | 51-63